Teresa Marie Volner alias The Glucose Genome Guru
Website · totalcarehealthsolutions.com
Practice location
6308 College Blvd
Overland Park, KS 66211
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 20 health claims, 6 run counter to or conflict with the published evidence, and 14 were not independently checked.
- Primary persuasion tactic: Diabetes doom framing.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Teresa Volner is serving up the full root-cause catechism: diabetes, DNA, oxidative stress, detox, supplements, coaching, and a free blueprint call to tie the whole bundle together. It’s the sort of polished metabolic mysticism that makes blood sugar sound like a personality test with a checkout page.
High grift signals
Score breakdown
Direct answer
Teresa Marie Volner is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. §65-2871 (Kansas Healing Arts Act)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Genetic testing can predict diabetes, Winners in Diabetes Program, The WINNERS in Diabetes Full Program, to struggle alone with diabetes, and Q: Can genetic testing predict diabetes?, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward supplements, lab panels, and paid programs that Teresa Marie Volner profits from.
Key findings
- Fear Mongering: This uses diabetes complications to scare the viewer into buying the program, even though the page is pitching unproven genetic and detox add-ons rather than standard diabetes care.see section ↓
- Claim "Manage Type 2 Diabetes with Genetic Testing": not supported by peer-reviewed evidence.see section ↓
- Claim "Type 2 diabetes can be traced to DNA / genetics as the hidden root cause": mixed in the medical literature.see section ↓
- NPI registry confirms Teresa Volner as Chiropractor (DC) in Kansas (NPI 1871717009).see section ↓
- Teresa Marie Volner shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Teresa Marie Volner is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. §65-2871 (Kansas Healing Arts Act)), these advertised activities appear outside Teresa Marie Volner's license (including conditions they merely list as ones they treat): Manage Type 2 Diabetes with Genetic Testing, Type…see section ↓
- 24 of 24 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
14 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Manage Type 2 Diabetes with Genetic Testing.
Manage Type 2 Diabetes with Genetic Testing
- Supports
- There is emerging, but limited, evidence that incorporating genetic information into the care of people with type 2 diabetes can modestly influence management processes or patient behaviors, though not clearly improve glycemic outcomes. A randomized clinical trial (GEM trial) in patients with type 2 diabetes used genetic testing for risk alleles related to complications and provided personalized genetic risk counselling; this improved self-efficacy and some attitudes but did not meaningfully improve hard clinical targets (blood pressure, lipids, HbA1c) beyond standard integrated care.[1] Reviews of pharmacogenetics in type 2 diabetes describe many gene–drug response associations and suggest that, if genotypes were routinely available, they could help refine drug choice and dosing as part of precision medicine strategies, though this is framed as future potential rather than current routine practice.[8][9][10] Precision medicine and personalized medicine reviews in diabetes note that genetic testing is clearly useful for monogenic diabetes (such as maturity-onset diabetes of the young) to guide diagnosis and choice of therapy, and argue that as genomic information becomes more available, it may increasingly support individualized management.[5][10][16]
- Contradicts
- High-quality evidence and current guidelines do not support the idea that genetic testing, as currently used, is a primary or stand‑alone tool to manage typical polygenic type 2 diabetes, nor that it reliably improves glycemic control or replaces established lifestyle and pharmacologic interventions. In the randomized GEM trial, adding genetic risk counselling based on testing did not significantly improve achievement of cardiometabolic targets compared with usual integrated care, indicating no clear clinical benefit on key outcome measures.[1] Pharmacogenomic reviews emphasize that type 2 diabetes is highly polygenic with many small‑effect variants, so the clinical impact of individual pharmacogenetic markers is modest, and current genetic tests do not robustly define pathophysiology or guide treatment decisions in routine type 2 diabetes care.[8][9][10] Major contemporary guidelines for type 2 diabetes in adults and youth focus on glycemic targets, lifestyle modification, and evidence‑based drug algorithms (metformin, GLP‑1 receptor agonists, SGLT2 inhibitors, insulin, etc.), and do not recommend routine genetic testing to manage standard type 2 diabetes; genetic testing is mainly discussed for differentiating monogenic diabetes or rare insulin‑resistance syndromes and for classification, not as a core management tool.[10][11][16][20] Overall, the evidence base for using genetic testing to drive day‑to‑day management of typical type 2 diabetes is weak, mainly conceptual or exploratory, and lacks large RCTs showing improved clinical outcomes compared with standard care.[8][9][10]
- Mainstream view
- The mainstream medical position is that management of type 2 diabetes should be based primarily on lifestyle modification, structured self‑management education, regular monitoring of glycemia, and stepwise use of validated pharmacologic therapies guided by clinical features and complications rather than by routine genetic testing.[4][7][13][17][19] Genetic factors are recognized as important contributors to risk and to rare diabetes subtypes, and genetic testing is recommended or strongly considered when monogenic diabetes (such as MODY) or atypical forms (for example, type A insulin resistance) are suspected, because results can significantly change diagnosis and treatment strategy.[10][11][16][20] For the common polygenic form of type 2 diabetes, expert reviews and guidelines view pharmacogenomics and genomic risk scores as promising tools for future precision medicine but not yet validated or cost‑effective for routine management; their use is largely confined to research or specialized settings.[5][8][9][10] Mainstream care therefore does not endorse the idea of “managing type 2 diabetes with genetic testing” as a primary or sufficient strategy, but rather sees genetic information as an adjunct that may occasionally refine classification or therapy choice, especially in non‑typical cases.[5][10][16][20]
“Manage Diabetes With Genetic Testing & Transform With Certainty.”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type 2 diabetes can be traced to DNA / genetics as the hidden root cause.
Type 2 diabetes can be traced to DNA / genetics as the hidden root cause
- Supports
- High-quality evidence shows that type 2 diabetes has a substantial genetic component: twin and family studies consistently estimate heritability in the roughly 25–80% range, with several large cohorts and meta-analyses clustering around 50–72% heritability.[8][9][10][11][12][14][15][16][19] Concordance rates for type 2 diabetes are markedly higher in monozygotic than dizygotic twins, indicating that sharing more DNA increases risk, which supports a major role for genetics in susceptibility.[9][11][12][14][19] First‑degree relatives of people with type 2 diabetes have about a three‑fold higher risk compared with those without a family history, and risk may approach 40–70% if one or both parents are affected, again indicating strong familial and genetic influence.[12][14] Genome‑wide association studies have identified over a hundred common risk variants and many loci that contribute to a polygenic risk background for type 2 diabetes, supporting the idea that DNA variants substantially influence overall risk.[13][14][16][18] Systematic reviews and meta‑analyses in various populations, including Sub‑Saharan Africa, show that having a positive family history is associated with roughly a three‑fold higher odds of type 2 diabetes and identify specific risk polymorphisms (for example in TCF7L2 and other genes) that contribute to disease susceptibility.[6] Authoritative reviews and genetic overviews describe type 2 diabetes as developing on a predisposing genetic background onto which environmental factors are superimposed, reinforcing the view that genetics forms a key, though not exclusive, part of the disease etiology.[1][8][12][14][19]
- Contradicts
- Although genetics clearly contributes to type 2 diabetes risk, high‑quality evidence does not support the idea that DNA or genetics alone are the hidden root cause in a simple or deterministic sense, because heritability estimates are moderate to high but far from 100%, and they vary substantially across studies and populations.[8][9][10][11][14][16][19] Twin studies and population‑based analyses repeatedly emphasize a multifactorial etiology, concluding that non‑genetic factors play a predominant role in determining whether a genetically predisposed individual progresses to overt type 2 diabetes.[11][19] Some cohorts, such as the Washington State Twin Registry, show heritability around 52% in older adults and little or no detectable genetic contribution in twins under 45, indicating that environmental and lifestyle factors become increasingly important and that DNA is not sufficient by itself to explain disease onset.[10][5][19] Reviews of gene–environment interaction and epigenetic work highlight that even among identical twins, one can develop type 2 diabetes while the other does not, with differences in gene activity and epigenetic marks linked to diet, adiposity, and other exposures, directly contradicting a purely DNA‑centric causal framing.[17][19][20] Environmental and lifestyle factors such as obesity, diet, physical inactivity, and broader metabolic and social determinants are recognized as major drivers of type 2 diabetes incidence worldwide, often necessary to unmask genetic susceptibility, which weakens any claim that genetics alone is the root cause.[1][19][20] Major reviews explicitly state that a susceptible genetic background appears to be necessary for overt diabetes only in rare monogenic or Mendelian forms, not in typical type 2 diabetes, and that most common cases arise from complex interactions between genes and environment.[1][12][14][19]
- Mainstream view
- The mainstream medical and scientific position is that type 2 diabetes is a complex, multifactorial disease caused by the interaction of a substantial but incomplete genetic predisposition with environmental and lifestyle factors such as obesity, diet, and physical activity.[1][8][12][14][19][20] Current evidence indicates that DNA and genetics confer important susceptibility and explain a significant proportion of variance in risk, but they do not function as a single hidden root cause, because many genetically predisposed individuals never develop the disease and many environmental changes can markedly modify risk and disease trajectory.[10][11][19][20] Expert reviews, twin studies, and genomic research converge on a model in which type 2 diabetes arises from a polygenic background, epigenetic modifications, and metabolic mechanisms that are strongly shaped by modifiable exposures, so standard practice is to treat genetics as one key layer within a broader causal framework rather than the primary or sole origin of disease.[1][8][12][14][19][20] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“What If the Secret to Reversing Type 2 Diabetes Has Been in Your DNA All Along?”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism.
The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism
- Supports
- There is substantial evidence that structured lifestyle and behavioral programs can improve blood sugar control in people with type 2 diabetes, particularly when they include diet, physical activity, and education, similar in concept to what the WINNERS in Diabetes Program claims to do, although this specific program itself has no indexed trials or peer‑reviewed evaluations identified. [8] Randomized and quasi‑experimental studies of comprehensive or commercial diabetes-tailored weight‑loss and behavior programs (e. g. , community and online programs, general comprehensive treatment programs, and commercial weight‑loss programs tailored for type 2 diabetes) consistently show modest but clinically relevant reductions in HbA1c and fasting blood glucose, supporting the general idea that a multi-component program can improve glycemic control and aspects of metabolism. [14][15][16] Online‑supervised exercise programs in older adults with type 2 diabetes have been shown in double‑blind randomized trials to lower fasting blood sugar, improve BMI, and enhance quality of life, supporting the claim that structured, supervised lifestyle interventions can improve blood sugar stability, energy, and overall metabolic health. [13] Family-based and community health behavior change interventions for diabetes show improved self-management and glycemic control, which indirectly supports the concept that coaching and social support as used in the program can help stabilize blood sugar and improve energy levels. [7] Dietary interventions such as the DASH diet and cinnamon supplementation have demonstrated improvements in fasting blood glucose and HbA1c, supporting that specific nutrition strategies embedded in a program can contribute to blood sugar stability and cardiometabolic health. Pharmacologic dopamine agonists (e. g. , bromocriptine) are FDA-approved for type 2 diabetes and systematic reviews and meta-analyses show they modestly lower HbA1c and fasting plasma glucose, supporting the broader mechanistic notion that targeted interventions on metabolism and neuroendocrine pathways can influence blood sugar regulation and metabolic variables.
- Contradicts
- No peer-reviewed trials, observational studies, or guideline documents specifically evaluating the WINNERS in Diabetes Program were identified, so there is no direct evidence that this branded program itself restores balance or stabilizes blood sugar, energy, digestion, and metabolism beyond generic expectations from lifestyle programs. [7] The program’s marketing claims of putting diabetes in remission naturally and restoring multiple domains (blood sugar stability, energy, digestion, metabolism) imply large and consistent effects; available evidence for analogous programs shows benefits that are typically modest in magnitude and variable across individuals, with glycemic improvements on the order of 0. [13][15][16] 3–1. 2% reductions in HbA1c rather than guaranteed remission. Existing high‑quality evidence for lifestyle and commercial programs largely focuses on glycemic outcomes, weight, and cardiometabolic risk factors, and does not consistently demonstrate specific improvements in digestion or global “metabolic balance” as broad claims, so the assertion that a proprietary program restores overall balance and digestion exceeds what is directly supported by clinical trials. [14] Systematic reviews of dopamine agonists and metabolic modulation show only moderate to low quality evidence and modest glycemic effects, highlighting that even well-studied targeted pharmacologic interventions do not typically produce the comprehensive, multi-domain restoration implied by the influencer’s claim. Major nutrition guidelines for chronic disease (ESPEN and ASPEN‑FELANPE) emphasize individualized clinical nutrition and appropriate use of enteral and parenteral support, but they do not endorse specific commercial programs like WINNERS in Diabetes, nor do they claim such programs can, by themselves, restore global metabolic balance or cure diabetes. [6][5][8]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic metabolic disease that can be substantially improved and sometimes brought into remission through evidence‑based interventions including structured lifestyle change (diet, physical activity, weight loss), appropriate pharmacotherapy, and management of comorbidities, but claims of universal remission or comprehensive restoration of balance from a single proprietary program are not supported without rigorous clinical trial data. [7][6][5][8][15][16] High‑quality evidence supports multi-component lifestyle and behavior change programs, including diabetes‑tailored commercial weight‑loss interventions, supervised exercise programs, and dietary strategies such as DASH Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [13][14]
“The WINNERS in Diabetes Program is a personalized system designed to restore balance to your body from blood sugar stability to energy, digestion, and metabolism.”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure DNA and oxidative stress testing can guide personalized diabetes management.
DNA and oxidative stress testing can guide personalized diabetes management
- Supports
- Oxidative stress is mechanistically linked to diabetes and its complications, and multiple reviews describe oxidative biomarkers such as 8-OHdG, MDA, and isoprostanes as potential markers of disease burden or complication risk. [19][20] A recent review also argues that oxidative stress biomarkers may help refine diagnosis, counseling, and personalized care in selected contexts, but it frames this as future-facing and context-dependent rather than established routine diabetes management. [17] The broader precision-medicine literature in diabetes supports using certain biomarkers and genotype information to tailor therapy in limited scenarios, such as C-peptide, HNF1A MODY, CYP2C9 variants affecting sulfonylurea response, and OCT1 variants affecting metformin intolerance. [18]
- Contradicts
- The evidence does not support routine DNA testing plus oxidative stress testing as a validated way to guide personalized diabetes management for most patients. [7][17][19] A recent review states that no oxidative stress biomarker has shown consistently replicated incremental prognostic value beyond established cardiometabolic risk models sufficient for routine clinical implementation, and that oxidative biomarkers remain primarily mechanistic and research tools. [5][18][20] The same review notes that lowering oxidative biomarkers has not been established as a validated mediator of clinical benefit. The diabetes precision-medicine reviews support genetics-guided care only for narrow, specific subgroups, not broad influencer-style claims that DNA testing in general can direct diabetes treatment for typical patients.
- Mainstream view
- Mainstream endocrinology and laboratory medicine view oxidative stress biomarkers as biologically interesting and potentially useful in research or limited specialist settings, but not as standard-of-care tools for routine personalized diabetes management. [17][18][19][20] Mainstream precision diabetes care uses established clinical measures and selectively uses genetics in a few well-defined scenarios, rather than general DNA or oxidative stress testing for all patients. [5] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Manage Type 2 Diabetes with DNA and Oxidative Stress Testing”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The program helps prevent kidney issues, nerve damage, and vision loss in diabetes.
The program helps prevent kidney issues, nerve damage, and vision loss in diabetes
No specific health claims of theirs were cross-checked against the literature.
“Assess your genetic odds to help prevent kidney issues, nerve damage and vision loss.”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Winners in Diabetes Program.
Winners in Diabetes Program
- Supports
- There is substantial evidence that structured lifestyle and behavioral programs can improve blood sugar control in people with type 2 diabetes, particularly when they include diet, physical activity, and education, similar in concept to what the WINNERS in Diabetes Program claims to do, although this specific program itself has no indexed trials or peer‑reviewed evaluations identified. [8] Randomized and quasi‑experimental studies of comprehensive or commercial diabetes-tailored weight‑loss and behavior programs (e. g. , community and online programs, general comprehensive treatment programs, and commercial weight‑loss programs tailored for type 2 diabetes) consistently show modest but clinically relevant reductions in HbA1c and fasting blood glucose, supporting the general idea that a multi-component program can improve glycemic control and aspects of metabolism. [14][15][16] Online‑supervised exercise programs in older adults with type 2 diabetes have been shown in double‑blind randomized trials to lower fasting blood sugar, improve BMI, and enhance quality of life, supporting the claim that structured, supervised lifestyle interventions can improve blood sugar stability, energy, and overall metabolic health. [13] Family-based and community health behavior change interventions for diabetes show improved self-management and glycemic control, which indirectly supports the concept that coaching and social support as used in the program can help stabilize blood sugar and improve energy levels. [7] Dietary interventions such as the DASH diet and cinnamon supplementation have demonstrated improvements in fasting blood glucose and HbA1c, supporting that specific nutrition strategies embedded in a program can contribute to blood sugar stability and cardiometabolic health. Pharmacologic dopamine agonists (e. g. , bromocriptine) are FDA-approved for type 2 diabetes and systematic reviews and meta-analyses show they modestly lower HbA1c and fasting plasma glucose, supporting the broader mechanistic notion that targeted interventions on metabolism and neuroendocrine pathways can influence blood sugar regulation and metabolic variables.
- Contradicts
- No peer-reviewed trials, observational studies, or guideline documents specifically evaluating the WINNERS in Diabetes Program were identified, so there is no direct evidence that this branded program itself restores balance or stabilizes blood sugar, energy, digestion, and metabolism beyond generic expectations from lifestyle programs. [7] The program’s marketing claims of putting diabetes in remission naturally and restoring multiple domains (blood sugar stability, energy, digestion, metabolism) imply large and consistent effects; available evidence for analogous programs shows benefits that are typically modest in magnitude and variable across individuals, with glycemic improvements on the order of 0. [13][15][16] 3–1. 2% reductions in HbA1c rather than guaranteed remission. Existing high‑quality evidence for lifestyle and commercial programs largely focuses on glycemic outcomes, weight, and cardiometabolic risk factors, and does not consistently demonstrate specific improvements in digestion or global “metabolic balance” as broad claims, so the assertion that a proprietary program restores overall balance and digestion exceeds what is directly supported by clinical trials. [14] Systematic reviews of dopamine agonists and metabolic modulation show only moderate to low quality evidence and modest glycemic effects, highlighting that even well-studied targeted pharmacologic interventions do not typically produce the comprehensive, multi-domain restoration implied by the influencer’s claim. Major nutrition guidelines for chronic disease (ESPEN and ASPEN‑FELANPE) emphasize individualized clinical nutrition and appropriate use of enteral and parenteral support, but they do not endorse specific commercial programs like WINNERS in Diabetes, nor do they claim such programs can, by themselves, restore global metabolic balance or cure diabetes. [6][5][8]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic metabolic disease that can be substantially improved and sometimes brought into remission through evidence‑based interventions including structured lifestyle change (diet, physical activity, weight loss), appropriate pharmacotherapy, and management of comorbidities, but claims of universal remission or comprehensive restoration of balance from a single proprietary program are not supported without rigorous clinical trial data. [7][6][5][8][15][16] High‑quality evidence supports multi-component lifestyle and behavior change programs, including diabetes‑tailored commercial weight‑loss interventions, supervised exercise programs, and dietary strategies such as DASH Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [13][14]
“Winners in Diabetes Program”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Full Program.
The WINNERS in Diabetes Full Program
No specific health claims of theirs were cross-checked against the literature.
“The WINNERS in Diabetes Full Program”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure to struggle alone with diabetes.
to struggle alone with diabetes
No specific health claims of theirs were cross-checked against the literature.
“to struggle alone with diabetes”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Why the WINNERS in Diabetes Program Changes Everything.
Why the WINNERS in Diabetes Program Changes Everything
No specific health claims of theirs were cross-checked against the literature.
“Why the WINNERS in Diabetes Program Changes Everything”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Q: Can genetic testing predict diabetes?.
Q: Can genetic testing predict diabetes?
No specific health claims of theirs were cross-checked against the literature.
“Q: Can genetic testing predict diabetes?”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Do you have genetic tendencies toward insulin resistance?.
Do you have genetic tendencies toward insulin resistance?
No specific health claims of theirs were cross-checked against the literature.
“Do you have genetic tendencies toward insulin resistance?”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Put Diabetes In Remission Forever!.
Put Diabetes In Remission Forever!
No specific health claims of theirs were cross-checked against the literature.
“Put Diabetes In Remission Forever!”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise DNA testing plus lifestyle and supplement recommendations will work for you as within their scope of practice.
DNA testing plus lifestyle and supplement recommendations will work for you
No specific health claims of theirs were cross-checked against the literature.
“It gives food, lifestyle, and supplement recommendations that will work for you.”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Teresa Marie Volner is not approved to offer Custom plans combine detox support, targeted nutrition, and clean supplements within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).
Custom plans combine detox support, targeted nutrition, and clean supplements
No specific health claims of theirs were cross-checked against the literature.
“Your custom plan combines detox support, targeted nutrition, and clean supplements chosen for your biology.”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
transcript · cited
This uses diabetes complications to scare the viewer into buying the program, even though the page is pitching unproven genetic and detox add-ons rather than standard diabetes care. Likely motive: Push anxious readers into a paid consult and bundled program
“help prevent kidney issues, nerve damage and vision loss”
transcript · cited
The page wraps a diabetes coaching funnel in medical-sounding authority while presenting nonstandard DNA, oxidative stress, and detox services as if they were clinical necessities. Likely motive: Borrow clinical credibility to sell a premium program
“doctor-led transformation system”
transcript · cited
Client testimonials are used as proof of effectiveness instead of controlled evidence, and the page offers no serious data showing diabetes remission from these methods. Likely motive: Substitute testimonials for evidence
“What my clients say”
transcript · cited
The pitch centers on paid testing as the gateway to treatment, even though the page does not show that these tests are standard or necessary for diabetes management. Likely motive: Sell testing before selling the protocol
“DNA & Oxidative Stress Testing”
transcript · cited
The free consultation is a classic lead capture step that feeds into a higher-ticket diabetes program, tests, supplements, and coaching. Likely motive: Convert visitors into consult leads and paid buyers
“Book your FREE, no-commitment Blueprint Call.”
transcript · cited
A branded proprietary system packages consultations, testing, supplements, detox, and coaching into one monetized pathway. Likely motive: Sell a branded care pathway instead of evidence-based diabetes care
“The WINNERS in Diabetes Program”
source material
The page shows a Fullscript supplement storefront with no obvious FTC-style disclosure on the same surface explaining whether the clinician earns from dispensary sales or referrals. Likely motive: Normalize supplement shopping without telling viewers about the money flow
Commerce & grift map
The money flow looks like scare content about diabetes complications, then a paid consult, then DNA/oxidative stress testing, then a branded coaching program, with Fullscript supplements layered in as the ongoing monetization engine. It is the classic root-cause funnel: convince the viewer that standard diabetes care missed the hidden cause, then sell the proprietary test-stack-supplement pathway that allegedly found it.
Fullscript
Supplement / productPays providers to recommendLow confidence
- Affiliate commission
- Dispensing markup
- Wholesale-to-retail markup
Practitioner dispensary model: typical markup or commission on supplement sales routed through a branded storefront.
Supplements pitched
- Fullscript Supplements
“Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
Labs pitched
- DNA & Oxidative Stress Testing
“DNA & Oxidative Stress Testing Understand your genetic blueprint and cellular resilience.”
How the money flows
- Lab testing referralUndisclosed Paid DNA and oxidative stress testing is used as the gateway product in the diabetes funnel. “DNA & Oxidative Stress Testing”
“DNA & Oxidative Stress Testing”
- Supplement brand dealUndisclosed Fullscript dispensary supplements are embedded directly in the treatment pathway. “Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
“Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
- Paid wellness plan / membershipUndisclosed A branded diabetes program, coaching, and 1:1 sessions are sold as the main offer. “The WINNERS in Diabetes Program”
“The WINNERS in Diabetes Program”
- Affiliate / promo linkUndisclosed Outbound commerce store links with strong affiliate or practitioner-markup signals, but no clear FTC-style material-connection disclosure on the page.
Store links detected
- Browse SupplementsHigh likelihood
“Practitioner supplement dispensary”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- FullscriptBrand
Promoted commerce partner
- Fullscript SupplementsBrand
Named on a surface without a compensation disclosure
- DNA & Oxidative Stress TestingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor, Internist · KS license T-01088.
Teresa Volner is presented as a doctor and diabetes authority, but the page does not clearly establish an MD or DO license. The bigger problem is credential inflation by implication: the site uses that title to market internal-medicine-style diabetes management, genetic interpretation, detox, and supplement selection as if broad medical competence were established.
- Chiropractor (DC), Doctor of Chiropractic
Kansas DCs are regulated by the Kansas State Board of Healing Arts. Scope is limited to chiropractic methods for musculoskeletal and nervous-system conditions, not general internal medicine, hormone replacement medicine, or primary disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: low
Kansas chiropractors are authorized to examine, analyze and diagnose interference with normal nerve transmission and expression and to adjust the spine and related articulations by manual or mechanical means, but may not prescribe drugs, perform surgery, or practice medicine and surgery. Their scope is focused on musculoskeletal and neuromuscular dysfunction, not on managing systemic diseases like diabetes as a primary-care physician would.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
24 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Manage Type 2 Diabetes with Genetic Testing Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Managing Type 2 diabetes with genetic testing is systemic disease management and laboratory-based care, which is not affirmatively authorized for chiropractors whose scope is limited to chiropractic diagnosis and adjustment of the spine and related structures. | Outside scope |
| Type 2 diabetes can be traced to DNA / genetics as the hidden root cause Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Making etiologic claims about the genetic root cause of diabetes as part of a service offering goes beyond chiropractic neuromusculoskeletal focus and implies medical/genetic counseling that is not affirmatively authorized in chiropractic scope. | Outside scope |
| The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Offering a program to restore blood sugar stability and metabolic function in diabetes constitutes treatment of a systemic endocrine disease, which Kansas chiropractic statutes do not affirmatively authorize. | Outside scope |
| DNA and oxidative stress testing can guide personalized diabetes management Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Using DNA and oxidative stress testing to guide diabetes management involves laboratory diagnostics and medical management of a systemic disease, which is outside the affirmative chiropractic scope of spinal and related structural care. | Outside scope |
| Genetic testing can predict diabetes Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Advertising genetic prediction of diabetes is a medical/genetic diagnostic service rather than chiropractic analysis of neuromusculoskeletal dysfunction, and such genetic testing authority is not granted in Kansas chiropractic law. | Outside scope |
| The program helps prevent kidney issues, nerve damage, and vision loss in diabetes Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Claiming to prevent diabetic complications like kidney disease, neuropathy, and retinopathy is management of serious systemic conditions beyond the musculoskeletal focus authorized for chiropractors. | Outside scope |
| Listed service Winners in Diabetes Program Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) A branded diabetes program offered by a chiropractor implies structured management of diabetes, which is not affirmatively within chiropractic scope in Kansas. | Outside scope |
| Listed service The WINNERS in Diabetes Full Program Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Labeling a full program for diabetes suggests comprehensive disease management services, which fall under the practice of medicine rather than chiropractic adjusting and related services. | Outside scope |
| Listed service to struggle alone with diabetes Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Using language about not struggling alone with diabetes in the context of services offered implies that the chiropractor will co-manage or manage diabetes, which exceeds chiropractic scope as defined around neuromusculoskeletal care. | Outside scope |
| Listed service Why the WINNERS in Diabetes Program Changes Everything Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Promoting a program as transformative for diabetes reflects an offer to treat or manage this systemic disease, which is outside the authorized chiropractic scope in Kansas. | Outside scope |
| Listed service Q: Can genetic testing predict diabetes? Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Framing and answering predictive genetic testing for diabetes as part of a chiropractic service package implies providing medical genetic diagnostic advice, which the chiropractic scope does not affirmatively include. | Outside scope |
| Listed service Do you have genetic tendencies toward insulin resistance? Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Assessing or suggesting assessment of genetic tendencies toward insulin resistance is genetic and endocrine diagnostic work beyond the scope of chiropractic analysis of nerve interference and related structures. | Outside scope |
| Listed service Put Diabetes In Remission Forever! Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Claiming to put diabetes into remission constitutes curative treatment of a systemic medical disease, which is not part of the affirmative chiropractic authorization in Kansas. | Outside scope |
| Diagnosing and treating Type 2 diabetes through genetic testing, detox, and supplement protocols Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing and treating Type 2 diabetes via genetic testing, detox, and supplements squarely falls under medical practice and is not affirmatively permitted within Kansas chiropractic scope focused on spinal adjustment and related therapies. | Outside scope |
| Claiming to reverse or manage diabetes via DNA-based root-cause work Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Reversing or managing diabetes through DNA-based root-cause protocols is specialized medical and genetic treatment not encompassed in the statutory chiropractic scope. | Outside scope |
| Providing supplement recommendations as diabetes treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Although chiropractors may recommend general nutritional supplements, explicitly positioning supplements as treatment for diabetes is treatment of a systemic disease outside the affirmatively defined chiropractic role. | Outside scope |
| DNA and oxidative stress testing for diabetes management Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Ordering or interpreting DNA and oxidative stress tests to manage diabetes is laboratory-based medical care not described within the Kansas chiropractic statutory scope. | Outside scope |
| Detox programs can reset the body and restore natural balance for metabolic problems Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Using detox programs to address metabolic problems like diabetes or insulin resistance goes beyond musculoskeletal-focused chiropractic care and ventures into systemic metabolic treatment not affirmatively authorized. | Outside scope |
| Metabolic weight loss can target stubborn weight linked to blood sugar imbalances Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Fullscript supplements support healthy glucose regulation Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Continuous glucose monitoring is being added as a service Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| DNA testing plus lifestyle and supplement recommendations will work for you Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Custom plans combine detox support, targeted nutrition, and clean supplements Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Free consultation used to identify metabolic blockers and determine whether DNA testing is the next step Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Kansas State Board of Healing Arts – Statutes & Regulations (official), Kansas State Board of Healing Arts – Practice Handbooks (official), Kansas State Board of Healing Arts – Home (official), Kansas State Board of Healing Arts
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Overland Park, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-22 05:39 UTC. The archive pane loads styles and images from the intake snapshot.
1 licensed-care path linked for out-of-scope claims.
Disclaimer hypocrisy
Teresa Volner hides behind the polite little shield that the test itself does not diagnose diabetes, then immediately turns around and hands out diabetes-management advice, supplement recommendations, and a personalized treatment pathway. That’s disclaimer cosplay: the liability language stays on, but the medical advice keeps flowing.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedTess Volner clinic / principal site (totalcarehealthsolutions.com)
- OwnedOfficial site (totalcarechiro.com)
- Linked entityLinked commerce or practice (pages.talktodrtess.com)
Funnel routes (third-party)
- Hosted routeFunnel route on fullscript.com
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission 6fIm_gjeu3fQmzeCiGWbl
Fight disinformation
Log a public thread where Teresa Marie Volner is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Teresa Marie Volner's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/6fIm_gjeu3fQmzeCiGWbl. White-coat charisma isn't evidence.
Full DTMB scan on Teresa Marie Volner: https://drtrustmebro.com/analyze/6fIm_gjeu3fQmzeCiGWbl
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Teresa Marie Volner. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Teresa Marie Volner, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Teresa Marie Volner. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: GGcM2EgKu6U2U77APV8Us
- Wall entry: /influencer/GGcM2EgKu6U2U77APV8Us
- Analysis ID: 6fIm_gjeu3fQmzeCiGWbl
- Source: https://totalcarehealthsolutions.com/home
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] A randomized clinical trial of genetic testing and personalized risk counselling in patients with type 2 diabetes receiving integrated care -The genetic testing and patient empowerment (GEM) trial - PubMed
- [2] Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics
- [3] Using Personalized Medicine in the Management of Diabetes Mellitus
- [4] Pharmacogenetics of type 2 diabetes mellitus, the route ... - PMC
- [5] PubMed indexed study
- [6] PubMed indexed study
- [7] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [8] When Is Parenteral Nutrition Appropriate?
- [9] Genetics
- [10] The Concordance and Heritability of Type 2 Diabetes in ...
- [11] Genetics of Type 2 Diabetes - NCBI - NIH
- [12] Heritability of Type 2 Diabetes in the Washington State Twin Registry
- [13] The effect of an online-supervised exercise program in older people with diabetes on fasting blood sugar, psychological resilience and quality of life: A double blind randomised controlled trial.
- [14] Commercial weight-loss programs in the management of obesity
- [15] Dopamine 2 agonists for the management of type 2 diabetes
- [16] Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes
- [17] Breathomics in Diabetes Management: A Noninvasive Approach for Precision Health Monitoring
- [18] Metabolomics in Traditional Chinese Medicine for Diabetes Mellitus: Mechanistic Insights, Biomarker Discovery, and Clinical Application Prospects
- [19] Oxidative stress biomarkers in type 2 diabetes - PubMed
- [20] Biomarkers of Oxidative Stress and Their Clinical Relevance in Type ...
- [21] Effect of intermittent fasting, portfolio-moderate-carbohydrate, and anti-inflammatory diets on cardio-metabolic status in pre-diabetic patients; an open-label randomized clinical trial
- [22] A Plant-Based Dietary Supplement Improves Measures of Metabolic ...
- [23] Effectiveness of Weight Loss Methods on Lifespan for ...
- [24] Study Details | NCT06061289 | Guided Metabolic Detox Program